Ergami Endoscopy Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $65K

  • Investors
  • 5

Ergami Endoscopy General Information

Description

Developer of an endoscopic robotic colonoscope insertion device designed to improve procedure productivity, reduce patient pain, and reduce the need for sedation. The company's device aims to relieve physical pain and musculoskeletal injuries associated with colonoscopy procedures, enabling doctors to reduce patients' pain and endoscopy-related injuries among endoscopists and nurses, while improving patient care processes.

Contact Information

Website
www.ergami.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 56 2nd Avenue
  • Suite 38
  • New York, NY 11215
  • United States
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Vertical(s)
LOHAS & Wellness, HealthTech
Corporate Office
  • 56 2nd Avenue
  • Suite 38
  • New York, NY 11215
  • United States

Ergami Endoscopy Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ergami Endoscopy Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant $65K Completed Startup
6. Grant 21-May-2026 Completed Startup
5. Grant 01-Jan-2025 Completed Startup
4. Seed Round 01-Dec-2024 Completed Startup
3. Grant 09-Jul-2024 Completed Startup
2. Accelerator/Incubator 02-Jul-2024 $65K Completed Startup
1. Angel (individual) 01-Jan-2023 $65K $65K Completed Startup
To view Ergami Endoscopy’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Ergami Endoscopy Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Ergami Endoscopy Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4633441-A1 Deployable flexible overtube Pending 16-Dec-2022
US-20240197154-A1 Deployable flexible overtube Pending 16-Dec-2022
WO-2024130138-A1 Deployable flexible overtube Inactive 16-Dec-2022 A61B1/00154

Ergami Endoscopy Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ergami Endoscopy Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Safety Council Corporation
Empire State Development Government
FuzeHub Not-For-Profit Venture Capital Minority
National Cancer Institute Government Minority
CNY Biotech Accelerator Accelerator/Incubator
To view Ergami Endoscopy’s complete investors history, request access »

Ready to get started?

Request a free trial

Ergami Endoscopy FAQs

  • When was Ergami Endoscopy founded?

    Ergami Endoscopy was founded in 2022.

  • Where is Ergami Endoscopy headquartered?

    Ergami Endoscopy is headquartered in New York, NY.

  • What is the size of Ergami Endoscopy?

    Ergami Endoscopy has 2 total employees.

  • What industry is Ergami Endoscopy in?

    Ergami Endoscopy’s primary industry is Medical Supplies.

  • Is Ergami Endoscopy a private or public company?

    Ergami Endoscopy is a Private company.

  • What is Ergami Endoscopy’s current revenue?

    The current revenue for Ergami Endoscopy is .

  • How much funding has Ergami Endoscopy raised over time?

    Ergami Endoscopy has raised $115K.

  • Who are Ergami Endoscopy’s investors?

    National Safety Council, Empire State Development, FuzeHub, National Cancer Institute, and CNY Biotech Accelerator have invested in Ergami Endoscopy.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process